Exact Sciences' Response to COVID-19
A Letter from our CEO, Kevin Conroy
What Is the Test
The Oncotype DX® test analyses the activity of 21 genes from the breast cancer tumour to provide an individual Recurrence Score® result, which is unique to the biology of a patient’s cancer.
The Oncotype DX test should be used when the benefit of chemotherapy for a patient is uncertain. The test increases both the patient and her doctor’s confidence in treatment decisions.
An individual question...an individual answer.
Visit these pages for further information on the Oncotype DX test, cancer-related terminology, and FAQs.